Global Infectious Disease POC Diagnostic 麻豆原创 Growth 2025-2031

Publication ID:

LPI04254914

Publication Date:

April 7, 2025

Pages:

107

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Infectious Disease POC Diagnostic market size is predicted to grow from US$ 1766 million in 2025 to US$ 3247 million in 2031; it is expected to grow at a CAGR of 10.7% from 2025 to 2031.
Diagnostic tests are important for diagnosing diseases and for improving global health. Traditional diagnoses ofinfectious disease resulted in inaccurate results and were time-consuming.This flaw led to the emergence of rapid.accurate, and portable point-of-care testing products in the market. POC testing enables faster diagnosis of infectious disease near the patient site providing quick results銆� Severalresearchers are now focused on the development of multiplex point-of-care diagnostic technologies. These MPOCTdevices consist of hybridization papers, array settings, bead technology, or microftuidic systems that reduce the assaysteps and provide diagnosis results in 15-30 minutes.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淚nfectious Disease POC Diagnostic Industry Forecast鈥� looks at past sales and reviews total world Infectious Disease POC Diagnostic sales in 2024, providing a comprehensive analysis by region and market sector of projected Infectious Disease POC Diagnostic sales for 2025 through 2031. With Infectious Disease POC Diagnostic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infectious Disease POC Diagnostic industry.
This Insight Report provides a comprehensive analysis of the global Infectious Disease POC Diagnostic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Infectious Disease POC Diagnostic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Infectious Disease POC Diagnostic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infectious Disease POC Diagnostic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infectious Disease POC Diagnostic.
This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Disease POC Diagnostic market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Lateral Flow Immunoassay
Agglutination Test
Flow-Through Test
Molecular Diagnostics
Others
Segmentation by Application:
Hospital Bedside
Urgent Care and Retail Clinics
麻豆原创 and Self-Testing
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
F. Hoffmann-La Roche
Thermo Fisher Scientific
Abbott Laboratories
Quest Diagnostics
BD
产颈辞惭茅谤颈别耻虫
Cardinal Health
Cepheid
Trinity Biotech
Quidel Corporation
Bio-Rad Laboratories
Key Questions Addressed in this Report
What is the 10-year outlook for the global Infectious Disease POC Diagnostic market?
What factors are driving Infectious Disease POC Diagnostic market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Infectious Disease POC Diagnostic market opportunities vary by end market size?
How does Infectious Disease POC Diagnostic break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Infectious Disease POC Diagnostic Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Infectious Disease POC Diagnostic by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Infectious Disease POC Diagnostic by Country/Region, 2020, 2024 & 2031
2.2 Infectious Disease POC Diagnostic Segment by Type
2.2.1 Lateral Flow Immunoassay
2.2.2 Agglutination Test
2.2.3 Flow-Through Test
2.2.4 Molecular Diagnostics
2.2.5 Others
2.3 Infectious Disease POC Diagnostic Sales by Type
2.3.1 Global Infectious Disease POC Diagnostic Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global Infectious Disease POC Diagnostic Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global Infectious Disease POC Diagnostic Sale Price by Type (2020-2025)
2.4 Infectious Disease POC Diagnostic Segment by Application
2.4.1 Hospital Bedside
2.4.2 Urgent Care and Retail Clinics
2.4.3 麻豆原创 and Self-Testing
2.4.4 Others
2.5 Infectious Disease POC Diagnostic Sales by Application
2.5.1 Global Infectious Disease POC Diagnostic Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global Infectious Disease POC Diagnostic Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global Infectious Disease POC Diagnostic Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Infectious Disease POC Diagnostic Breakdown Data by Company
3.1.1 Global Infectious Disease POC Diagnostic Annual Sales by Company (2020-2025)
3.1.2 Global Infectious Disease POC Diagnostic Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Infectious Disease POC Diagnostic Annual Revenue by Company (2020-2025)
3.2.1 Global Infectious Disease POC Diagnostic Revenue by Company (2020-2025)
3.2.2 Global Infectious Disease POC Diagnostic Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Infectious Disease POC Diagnostic Sale Price by Company
3.4 Key Manufacturers Infectious Disease POC Diagnostic Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Infectious Disease POC Diagnostic Product Location Distribution
3.4.2 Players Infectious Disease POC Diagnostic Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Infectious Disease POC Diagnostic by Geographic Region
4.1 World Historic Infectious Disease POC Diagnostic 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Infectious Disease POC Diagnostic Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Infectious Disease POC Diagnostic Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Infectious Disease POC Diagnostic 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Infectious Disease POC Diagnostic Annual Sales by Country/Region (2020-2025)
4.2.2 Global Infectious Disease POC Diagnostic Annual Revenue by Country/Region (2020-2025)
4.3 Americas Infectious Disease POC Diagnostic Sales Growth
4.4 APAC Infectious Disease POC Diagnostic Sales Growth
4.5 Europe Infectious Disease POC Diagnostic Sales Growth
4.6 Middle East & Africa Infectious Disease POC Diagnostic Sales Growth
5 Americas
5.1 Americas Infectious Disease POC Diagnostic Sales by Country
5.1.1 Americas Infectious Disease POC Diagnostic Sales by Country (2020-2025)
5.1.2 Americas Infectious Disease POC Diagnostic Revenue by Country (2020-2025)
5.2 Americas Infectious Disease POC Diagnostic Sales by Type (2020-2025)
5.3 Americas Infectious Disease POC Diagnostic Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infectious Disease POC Diagnostic Sales by Region
6.1.1 APAC Infectious Disease POC Diagnostic Sales by Region (2020-2025)
6.1.2 APAC Infectious Disease POC Diagnostic Revenue by Region (2020-2025)
6.2 APAC Infectious Disease POC Diagnostic Sales by Type (2020-2025)
6.3 APAC Infectious Disease POC Diagnostic Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Infectious Disease POC Diagnostic by Country
7.1.1 Europe Infectious Disease POC Diagnostic Sales by Country (2020-2025)
7.1.2 Europe Infectious Disease POC Diagnostic Revenue by Country (2020-2025)
7.2 Europe Infectious Disease POC Diagnostic Sales by Type (2020-2025)
7.3 Europe Infectious Disease POC Diagnostic Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Infectious Disease POC Diagnostic by Country
8.1.1 Middle East & Africa Infectious Disease POC Diagnostic Sales by Country (2020-2025)
8.1.2 Middle East & Africa Infectious Disease POC Diagnostic Revenue by Country (2020-2025)
8.2 Middle East & Africa Infectious Disease POC Diagnostic Sales by Type (2020-2025)
8.3 Middle East & Africa Infectious Disease POC Diagnostic Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Infectious Disease POC Diagnostic
10.3 Manufacturing Process Analysis of Infectious Disease POC Diagnostic
10.4 Industry Chain Structure of Infectious Disease POC Diagnostic
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Infectious Disease POC Diagnostic Distributors
11.3 Infectious Disease POC Diagnostic Customer
12 World Forecast Review for Infectious Disease POC Diagnostic by Geographic Region
12.1 Global Infectious Disease POC Diagnostic 麻豆原创 Size Forecast by Region
12.1.1 Global Infectious Disease POC Diagnostic Forecast by Region (2026-2031)
12.1.2 Global Infectious Disease POC Diagnostic Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Infectious Disease POC Diagnostic Forecast by Type (2026-2031)
12.7 Global Infectious Disease POC Diagnostic Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 F. Hoffmann-La Roche
13.1.1 F. Hoffmann-La Roche Company Information
13.1.2 F. Hoffmann-La Roche Infectious Disease POC Diagnostic Product Portfolios and Specifications
13.1.3 F. Hoffmann-La Roche Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 F. Hoffmann-La Roche Main Business Overview
13.1.5 F. Hoffmann-La Roche Latest Developments
13.2 Thermo Fisher Scientific
13.2.1 Thermo Fisher Scientific Company Information
13.2.2 Thermo Fisher Scientific Infectious Disease POC Diagnostic Product Portfolios and Specifications
13.2.3 Thermo Fisher Scientific Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Thermo Fisher Scientific Main Business Overview
13.2.5 Thermo Fisher Scientific Latest Developments
13.3 Abbott Laboratories
13.3.1 Abbott Laboratories Company Information
13.3.2 Abbott Laboratories Infectious Disease POC Diagnostic Product Portfolios and Specifications
13.3.3 Abbott Laboratories Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Abbott Laboratories Main Business Overview
13.3.5 Abbott Laboratories Latest Developments
13.4 Quest Diagnostics
13.4.1 Quest Diagnostics Company Information
13.4.2 Quest Diagnostics Infectious Disease POC Diagnostic Product Portfolios and Specifications
13.4.3 Quest Diagnostics Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Quest Diagnostics Main Business Overview
13.4.5 Quest Diagnostics Latest Developments
13.5 BD
13.5.1 BD Company Information
13.5.2 BD Infectious Disease POC Diagnostic Product Portfolios and Specifications
13.5.3 BD Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 BD Main Business Overview
13.5.5 BD Latest Developments
13.6 产颈辞惭茅谤颈别耻虫
13.6.1 产颈辞惭茅谤颈别耻虫 Company Information
13.6.2 产颈辞惭茅谤颈别耻虫 Infectious Disease POC Diagnostic Product Portfolios and Specifications
13.6.3 产颈辞惭茅谤颈别耻虫 Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 产颈辞惭茅谤颈别耻虫 Main Business Overview
13.6.5 产颈辞惭茅谤颈别耻虫 Latest Developments
13.7 Cardinal Health
13.7.1 Cardinal Health Company Information
13.7.2 Cardinal Health Infectious Disease POC Diagnostic Product Portfolios and Specifications
13.7.3 Cardinal Health Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Cardinal Health Main Business Overview
13.7.5 Cardinal Health Latest Developments
13.8 Cepheid
13.8.1 Cepheid Company Information
13.8.2 Cepheid Infectious Disease POC Diagnostic Product Portfolios and Specifications
13.8.3 Cepheid Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Cepheid Main Business Overview
13.8.5 Cepheid Latest Developments
13.9 Trinity Biotech
13.9.1 Trinity Biotech Company Information
13.9.2 Trinity Biotech Infectious Disease POC Diagnostic Product Portfolios and Specifications
13.9.3 Trinity Biotech Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Trinity Biotech Main Business Overview
13.9.5 Trinity Biotech Latest Developments
13.10 Quidel Corporation
13.10.1 Quidel Corporation Company Information
13.10.2 Quidel Corporation Infectious Disease POC Diagnostic Product Portfolios and Specifications
13.10.3 Quidel Corporation Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Quidel Corporation Main Business Overview
13.10.5 Quidel Corporation Latest Developments
13.11 Bio-Rad Laboratories
13.11.1 Bio-Rad Laboratories Company Information
13.11.2 Bio-Rad Laboratories Infectious Disease POC Diagnostic Product Portfolios and Specifications
13.11.3 Bio-Rad Laboratories Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Bio-Rad Laboratories Main Business Overview
13.11.5 Bio-Rad Laboratories Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.